Skip to content

Addiction: all studies

Page 290 of 857: studies 2,891 to 2,900 of 8,563, newest first. Back to the addiction overview

Research

MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up.

Alcohol and Alcoholism May 14, 2025 Hannah Thurgur, Ben Sessa, Laurie Higbed et al. 3 citations

Safety and tolerability data from the first open-label feasibility study of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for alcohol use disorder was recently published. This paper presents a Bayesian analysis of the impact of MDMA-assisted psychotherapy on treatment success, defined as 2-level reduction in the World Health Organization (WHO) drinking risk at the 3 months...

N-methyl-d-aspartate receptor hypofunction causes recurrent and transient failures of perceptual inference.

Brain May 13, 2025 Veith Weilnhammer, Marcus Rothkirch, Deniz Yilmaz et al. 11 citations

Perception integrates external sensory signals with internal predictions that reflect prior knowledge about the world. Previous research suggests that this integration is governed by slow alternations between an external mode, driven by sensory signals, and an internal mode, shaped by prior knowledge. Using a double-blind, placebo-controlled, cross-over experiment in healthy human participants,...

DOI: 10.1093/brain/awaf011 (opens in new tab) Full text (opens in new tab) Ketamine Bistable perception Predictive processing Psychosis +6

Shifting Narratives in Media Coverage Across a Decade of Drug Discourse in the Philadelphia Inquirer: Qualitative Sentiment Analysis.

JMIR infodemiology May 13, 2025 Layla Bouzoubaa, Ramtin Ehsani, Preetha Chatterjee et al. 3 citations

The media has immense power in shaping public narratives surrounding sensitive topics such as substance use. Its portrayals can unintentionally fuel harmful stereotypes and stigma, negatively impacting individuals struggling with addiction, influencing policy decisions, and hindering broader public health efforts. This study aimed to examine how the regional newspaper, The Philadelphia...

DOI: 10.2196/56004 (opens in new tab) Full text (opens in new tab) Drug use Infodemiology Media analysis Natural language processing +4

Pharmacological characterisation of JNJ-78911118, a novel, centrally-penetrant, selective GluN2A antagonist.

British Journal of Pharmacology May 13, 2025 Brian Lord, Sirak Simavorian, Ian Fraser et al. 2 citations

Non-selective NMDA receptor antagonism produces rapid symptom improvement in treatment-resistant depression; however, associated side effects necessitate medical oversight during administration. We hypothesised that selective GluN2A antagonism could provide similar efficacy with an improved side effect profile. Here, we report the pharmacology of JNJ-78911118, a brain-penetrant, GluN2A...

Three cytochrome P450 enzymes consecutively catalyze the biosynthesis of furanoclerodane precursors in Salvia species.

Plant communications May 12, 2025 Ruoxi Lin, Haixiu Li, Yiren Xiao et al.

Salvia species native to the Americas are rich in valuable bioactive furanoclerodanes like the psychoactive salvinorin A found in Salvia divinorum, which is used in the treatment of opioid addiction. However, relatively little is known about their biosynthesis. To address this, we investigated the biosynthesis of salviarin, the most abundant furanoclerodane structure in the ornamental sage...

DOI: 10.1016/j.xplc.2025.101286 (opens in new tab) Full text (opens in new tab) Salvia divinorum Salvia splendens Cytochrome p450 Diterpenoid metabolism +2

Cognition With and Beyond the Brain: Assemblages, Endosomatization, and AI-Driven Sensory Technologies

Antikythera Digital Journal May 10, 2025 Daniele Cavalli

This paper explores the potential for reconceptualizing cognition beyond brain-centered and anthropocentric readings, highlighting the entanglement between the body, the environment, and emerging technologies. Critiquing the limitations of computationalist and reductionist perspectives as well as rejecting any possible unifying definition of the phenomenon of cognition, I advocate for a...

The relational dimension in mindfulness intervention effects: results of a randomized controlled trial of mindfulness-based childbirth and parenting.

BMC Pregnancy and Childbirth May 10, 2025 Heidemarie K Laurent, Katherine L Haigler, Marissa D Sbrilli et al. 5 citations

Although secular mindfulness interventions draw from contemplative traditions emphasizing relationality, evidence for impacts of such interventions on relational outcomes remains inconsistent. This study was designed to clarify conditions under which mindfulness training can improve relational functioning in a perinatal context where quality of relationship-building carries particularly...

The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field

Neuroscience & Biobehavioral Reviews May 9, 2025 Rotem Petranker, Benjamin Tsang, Omer A. Syed 3 citations

Microdosing, the repeated use of psychedelic substances at low doses, is growing in popularity among recreational consumers. While this practice is associated with many benefits to mood, well-being and health, research in this area is in its early stages and predominantly centered on human applications. In this narrative review, we synthesize the findings from studies investigating the effects...

Enhanced ERK activity extends ketamine's antidepressant effects by augmenting synaptic plasticity.

Science May 8, 2025 Z Zack Ma, Natalie J Guzikowski, Ji-Woon Kim et al. 44 citations

Repeated ketamine treatment to maintain a rapid antidepressant effect can lead to side effects over time, highlighting an unmet clinical need for sustaining this drug's antidepressant action from a single administration. Ketamine-induced synaptic potentiation at CA3-CA1 synapses has been proposed to be a key synaptic substrate for antidepressant action. Here, we found that ketamine-induced...

DOI: 10.1126/science.abb6748 (opens in new tab) Full text (opens in new tab) Depression Ketamine therapy Mental health treatment Brain chemistry

(R)-ketamine induces mGlu5 receptor-dependent antidepressant-like effects in the chronic unpredictable mild stress model of depression in mice.

Psychopharmacology May 8, 2025 Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, Agata Faron-Górecka et al. 1 citation

(S)-Ketamine, which is used to treat depression, has significant undesirable effects and has potential for abuse. A safe alternative to (S)-ketamine is (R)-ketamine. The relationship between (R)-ketamine and the mGlu5 receptor is unknown, although screening tests indicate the possibility of potentiation of the antidepressant effect of (R)-ketamine by the mGlu5 receptor negative allosteric...